文献速递类风湿关节炎

多模态整合蛋白互作组与基因组及分子数据揭示类风湿关节炎不同内型

Multimodal Integration of Protein Interactomes With Genomic and Molecular Data Discovers Distinct Rheumatoid Arthritis Endotypes.
PubMed 文献 · Arthritis Rheumatol · 2026-03-09

该研究利用Rheumatoid Arthritis Comparative Effectiveness Research队列(555例CCP+/RF+ RA和384例CCP-/RF+ RA),整合网络为基础的全基因组关联研究与多组学数据,发现两组间存在显著遗传力差异,鉴定出14个 putative 基因模块(含HLA位点外基因)解释遗传差异,并验证4个模块,提示血液可反映关节分子程序,支持精准分层治疗。

要点

  • CCP+/RF+与CCP-/RF+ RA之间存在显著遗传力差异。
  • 网络GWAS鉴定14个基因模块解释两组遗传差异,验证其中4个。
  • 滑膜组织疾病相关基因模块亦见于外周血,支持血液分层。

核心结论

  • 网络方法可揭示CCP+/RF+与CCP-/RF+ RA的不同遗传风险因素,解释临床病程与治疗反应差异,支持精准治疗策略开发。

研究设计与样本

  • 基于Rheumatoid Arthritis Comparative Effectiveness Research队列,纳入555例CCP+/RF+ RA和384例CCP-/RF+ RA患者,整合网络为基础的全基因组关联研究与多组学数据。

主要发现

  • CCP+/RF+与CCP-/RF+ RA两组间存在显著遗传力差异。
  • 网络GWAS鉴定14个 putative 基因模块(含HLA位点外基因)解释两组遗传差异。
  • 遗传力分区和多变量表达分析验证4个模块,揭示表型差异的新遗传位点。
  • 滑膜组织中检测到的疾病相关基因模块亦见于外周血,提示关节特异性分子程序可系统反映。

临床怎么用

  • 血液检测可能捕获关节中活跃的致病机制,实现RA患者实际分层。
  • CCP+/RF+与CCP-/RF+ RA的遗传差异解释不同临床病程和治疗反应,支持精准导向治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Rheumatoid arthritis (RA) is a heterogeneous autoimmune disease characterized by clinical and molecular heterogeneity, notably in the presence of anti-cyclic citrullinated peptide (CCP) antibodies. Patients with CCP+ RA exhibit more severe disease progression and distinct treatment responses compared to patients with CCP- RA. Although previous studies have investigated cellular and molecular differences between these subtypes, their genetic differences are understudied. METHODS: We leveraged the Rheumatoid Arthritis Comparative Effectiveness Research cohort, comprising 555 patients with CCP+/rheumatoid factor (RF)+ RA and 384 patients with CCP-/RF+ RA. Using a novel framework, we integrated a network-based genome-wide association study (GWAS) with multiomic data to uncover corresponding genetic and molecular differences. RESULTS: We uncovered a significant heritability difference between these disease groups. Network-based GWAS uncovered 14 putative gene modules, including many genes outside the HLA loci, that explained genetic differences between CCP+/RF+ and CCP-/RF+ RA. Heritability partitioning and multivariate expression analyses validated four modules, highlighting novel genetic loci underlying phenotypic differences. Module functional significance was established using multiple orthogonal cohorts, underscoring their biologic relevance. CONCLUSION: Our findings demonstrate the use of network-based approaches in revealing differential genetic risk factors underlying CCP+/RF+ and CCP-/RF+ RA. Disease-associated gene modules detected in synovial tissue were also observed in peripheral blood, indicating joint-specific molecular programs are reflected systemically. This cross-tissue concordance highlights the potential for blood-based assays to capture pathogenic mechanisms active in the joints, enabling practical patient stratification. Our findings highlight why patients with CCP+/RF+ and CCP-/RF+ RA exhibit distinct clinical courses and therapeutic responses, supporting precision-guided treatment strategy development in RA.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Rahimikollu J, Guha Roy P, Kishore A, et al. Multimodal Integration of Protein Interactomes With Genomic and Molecular Data Discovers Distinct Rheumatoid Arthritis Endotypes. Arthritis Rheumatol. 2026. PMID: 41670344. doi:10.1002/art.70091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。